Rationale: The association between idiopathic pulmonary fibrosis (IPF) and lung cancer has
been previously reported. However, there is the potential for significant confounding by age …

Background There is an urgent need for biomarkers to better stratify patients with idiopathic
pulmonary fibrosis by risk for lung transplantation allocation who have the same clinical …

Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by progressive
lung scarring due to unknown injurious stimuli ultimately leading to respiratory failure …

Pulmonary fibrosis is an irreversible lung disorder with predictable decline in lung function
leading to respiratory insufficiency. Incidence of pulmonary fibrosis has been apparently …

Chronic lung diseases, such as idiopathic pulmonary fibrosis (IPF) and chronic obstructive
pulmonary disease (COPD), are major leading causes of death worldwide and are generally …

Introduction: Treatment of interstitial lung diseases (ILDs) other than idiopathic pulmonary
fibrosis (IPF) often includes systemic corticosteroids. Use of steroid-sparing agents is …

Idiopathic pulmonary fibrosis (IPF) is a progressive and generally lethal lung disease with a
high mortality rate. Current therapeutic drugs exhibit limited efficacy but severe adverse …

Idiopathic pulmonary fibrosis (IPF) is a debilitating chronic progressive and fibrosing lung
disease that culminates in the destruction of alveolar integrity and dismal prognosis. Its …

Background Lung disease caused by exposure to chemical substances such as
polyhexamethylene guanidine (PHMG) used in humidifier disinfectants (HDs) has been …

Background Human telomerase reverse transcriptase (hTERT) is the catalytic subunit of
telomerase enzyme, which adds nucleotides to telomeres and counteracts their length …